Malignant pleural mesothelioma

Phase II study of sunitinib as second-line therapy in malignant pleural mesothelioma (MPM)

(2017) A. K. Nowak et al.   JOURNAL OF CLINICAL ONCOLOGY

Pemetrexed Plus Cisplatin or Pemetrexed Plus Carboplatin for Chemonaïve Patients with Malignant Pleural Mesothelioma: Results of the International Expanded Access Program

(2010) Armando Santoro et al.   Journal of Thoracic Oncology

Diagnostic and Prognostic Value of Soluble Mesothelin-Related Proteins in Patients with Malignant Pleural Mesothelioma in Comparison with Benign Asbestosis and Lung Cancer

(2010) Joachim Schneider et al.   Journal of Thoracic Oncology

Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry

(2010) Kei Kushitani et al.   PATHOLOGY INTERNATIONAL

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials

(2008) G L Ceresoli et al.   BRITISH JOURNAL OF CANCER

Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma

(2008) J B Sørensen et al.   BRITISH JOURNAL OF CANCER

Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma

(2008) Paolo A. Zucali et al.   CANCER

Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma

(2008) David M. Jackman et al.   CANCER

A Conditional Mouse Model for Malignant Mesothelioma

(2008) Johan Jongsma et al.   CANCER CELL

Arginine deiminase, a potential anti-tumor drug

(2008) Ye Ni et al.   CANCER LETTERS

A Phase 1 Pharmacokinetic and Pharmacodynamic Study of the Histone Deacetylase Inhibitor Belinostat in Patients with Advanced Solid Tumors

(2008) N. L. Steele et al.   CLINICAL CANCER RESEARCH

PTEN expression is a strong predictor of survival in mesothelioma patients☆

(2008) Isabelle Opitz et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Phase II Trial of Pemetrexed and Gemcitabine in Chemotherapy-Naïve Malignant Pleural Mesothelioma

(2008) Pasi A. Jänne et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Trial of Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care in Previously Treated Patients With Advanced Malignant Pleural Mesothelioma

(2008) Jacek Jassem et al.   JOURNAL OF CLINICAL ONCOLOGY

Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients

(2008) Raja M. Flores et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

(2008) Martin F Muers et al.   LANCET

Non-invasive diagnosis of pleural malignancies: The role of tumour markers

(2008) Michel M. van den Heuvel et al.   LUNG CANCER

The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma

(2008) Justin Stebbing et al.   LUNG CANCER

Advances in the systemic therapy of malignant pleural mesothelioma

(2008) Dean A Fennell et al.   Nature clinical practice. Oncology

Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)

(2007) B. Castagneto et al.   ANNALS OF ONCOLOGY

Soluble Mesothelin-Related Peptide Level Elevation in Mesothelioma Serum and Pleural Effusions

(2007) Harvey I. Pass et al.   ANNALS OF THORACIC SURGERY

Mesothelin targeted cancer immunotherapy

(2007) Raffit Hassan et al.   EUROPEAN JOURNAL OF CANCER

Current state and future directions of pleural mesothelioma imaging

(2007) Samuel G. Armato et al.   LUNG CANCER

Gene methylation in pleural mesothelioma: Correlations with clinico-pathological features and patient's follow-up

(2007) Annarita Destro et al.   LUNG CANCER